NCT Number: NCT02174926
LASER Trial. LAparoscopic Elective Sigmoid Resection Following divERticulitis - a Multicenter, Prospective, Randomized Clinical Trial
The purpose of this study is to find out whether elective sigmoid resection will improve quality of life compared to conservative treatment with lifestyle guidance and fiber supplement in patients with a recurrent or complicated diverticulitis.
This study is active but is not currently recruiting participants.
Key information
Conditions
Age range
18 year–75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Helsinki University Central Hospital, Jorvi Hospital, Espoo, Finland
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Recurrent left colon diverticulitis (minimum 3 within 2 years, at least 1 confirmed with CT)
OR
- Earlier complicated left colon diverticulitis
OR
- Prolonged (over 3 months) pain or disturbance in bowel habits after a CT-confirmed left colon diverticulitis
Exclusion criteria
- Multimorbidity that prevents elective surgery
- Contraindication to laparoscopy
- Colonic stricture
- Fistula (e.g. colocutaneous, colovaginal, colovesical)
- Active malignancy
- Earlier resection of sigmoid colon or rectum
- Acute diverticulitis that has not settled
- Colonoscopy/sigmoidoscopy/virtual colonoscopy not performed within 2 years
- Age < 18 or > 75 years
- Pregnancy
- Inability to answer health surveys (e.g. dementia, psychiatric condition)
Treatment and study plan
conservative treatment
Dietary SupplementWritten lifestyle guidance and fiber supplements
Primary outcomes
-
Gastrointestinal quality of life-index change at 6 months
Time frame: 6 months from randomization
Difference in gastrointestinal quality of life-index (GIQLI) at randomization and 6 months from randomization.
Secondary outcomes
-
GIQLI at 12, 24, 48, and 96 months
Time frame: 12, 24, 48, and 96 months from randomization
-
Short form (SF) 36 Health survey score at 6, 12, 24, 48, and 96 months
Time frame: 6, 12, 24, 48, and 96 months from randomization
-
Recurrence and severity of recurrent diverticulitis
Time frame: 0 - 96 months from randomization
-
Need of emergency surgery due to diverticulitis
Time frame: 0 - 96 months from randomization
Whether or not patient has undergone emergency surgery due to diverticulitis during follow-up period. Assessment will be carried out by patient questionnaire and search for patient records.
-
Need of elective sigmoid resection due to diverticulitis (conservative arm)
Time frame: 0 - 96 months from randomization
Whether or not patient has undergone elective sigmoid resection due to diverticulitis during follow-up period. Assessment will be carried out by patient questionnaire and search for patient records.
-
Complications due to elective sigmoid resection
Time frame: 0 - 96 months from randomization
-
Mortality
Time frame: 0 - 96 months
-
Complications of diverticular disease
Time frame: 0 - 96 months
-
Stoma rate
Time frame: 0 - 96 months from randomization
Sponsors and collaborators
Lead sponsor
Helsinki University Central Hospital
Other
Registry information
Acronym: LASER
Important dates
- Study start
- 2014
- Primary completion
- 2019
- Study completion
- 2027
- First posted
- Jun 26, 2014
- Registry last updated
- Aug 24, 2020
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis
NCT06687382
Digestive System Diseases, Diverticular Diseases
Madrid, Spain
View Trial DetailsImproving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers
NCT02222844
Cancer, Colon, Sigmoid
Huntingdon, Cambridgeshire, United Kingdom
View Trial DetailsPatient-Centred Innovations for Persons With Multimorbidity - Ontario
NCT02742597
Alzheimer Disease, Alzheimer's Disease
London, Ontario, Canada
View Trial DetailsPatient-Centred Innovations for Persons With Multimorbidity - Quebec
NCT02789800
Alzheimer Disease, Alzheimer's Disease
Chicoutimi, Quebec, Canada
View Trial Details